COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,959 Articles (22,604 medRxiv, 8,355 bioRxiv)

Most recent first Previous |  Page 2417: Articles 24161-24170  | Next

Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2
Oark, J.-G., Oladduni, F. S., Chiem, K., Ye, C., Pipenbrink, M., Moran, T., Walter, M., Kobie, J., Martinez-Sobrido, L.
10.1101/2020.07.22.216648 — Posted: 2020-07-23
SARS-CoV-2 receptor Angiotensin I-Converting Enzyme type 2 is expressed in human pancreatic islet β-cells and is upregulated by inflammatory stress
Fignani, D., Licata, G., Brusco, N., Nigi, L., Grieco, G. E., Marselli, L., Overbergh, L., Gysemans, C., Colli, M. L., Marchetti, P., Mathieu, C., Eizirik, D. L., Sebastiani, G., Dotta, F.
10.1101/2020.07.23.208041 — Posted: 2020-07-23
From people to Panthera: Natural SARS-CoV-2 infection in tigers and lions at the Bronx Zoo
McAloose, D., Laverack, M., Wang, L., Killian, M. L., Caserta, L. C., Mitchell, P. K., Queen, K., Mauldin, M. R., Cronk, B. D., Bartlett, S. L., Sykes, J. M., Zec, S., Ingerman, K., Stokol, T., Frederikson, R., Delaney, M. A., Ivancic, M., Jenkins-Moore, M., Mozingo, K., Franzen, K., Hines Bergeson, N., Goodman, L., Wang, H., Wang, S., Yuan, F., Fang, Y., Olmstead, C., McCann, C., Thomas, P., Goodrich, E., Elvinger, F., Slavinski, S., Smith, D. C., Calle, P. P., Terio, K., Torchetti, M. K., Diel, D. G.
10.1101/2020.07.22.213959 — Posted: 2020-07-23 Discussion: Offsite
Transcriptional response modules characterise IL-1 and IL-6 activity in COVID-19
Bell, L. C. K., Noursadeghi, M., Pollara, G.
10.1101/2020.07.22.202275 — Posted: 2020-07-23
Phylogeny of the COVID-19 Virus SARS-CoV-2 by Compression
Vitanyi, P. M. B., Cilibrasi, R. L.
10.1101/2020.07.22.216242 — Posted: 2020-07-23
SECOND WEEK METHYL-PREDNISOLONE PULSES IMPROVE PROGNOSIS IN PATIENTS WITH SEVERE CORONAVIRUS DISEASE 2019 PNEUMONIA: AN OBSERVATIONAL COMPARATIVE STUDY USING ROUTINE CARE DATA.
Ruiz-Irastorza, G., Pijoan, J.-I., Bereciartua, E., Dunder, S., Dominguez, J., Garcia-Escudero, P., Rodrigo, A., Gomez-Carballo, C., Varona, J., Guio, L., Ibarrola, M., Ugarte, A., Martinez-Berriotxoa, A.
10.1101/2020.07.16.20152868 — Posted: 2020-07-23 Discussion: Onsite
Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19
LOFGREN, S. M. M., Nicol, M. R., Bangdiwala, A. S., Pastick, K. A., Okafor, E. C., Skipper, C. P., Pullen, M. F., Engen, N. W., Abassi, M., Williams, D. A., Nascene, A. A., Axelrod, M. L., Lother, S. A., MacKenzie, L. J., Drobot, G., Marten, N., Cheng, M. P., Zarychanshi, R., Schwartz, I. S., Silverman, M., Chagla, Z., Kelley, L. E., McDonald, E. G., Lee, T. C., Hullsiek, K. H., Boulware, D. R., Rajasingham, R.
10.1101/2020.07.16.20155531 — Posted: 2020-07-23 Discussion: Onsite
A national consensus management pathway for Paediatric Inflammatory Multisystem Syndrome - Temporally associated with SARS-CoV-2 (PIMS-TS): The results of a national Delphi process
Harwood, R., Allin, B., Jones, C. E., Whittaker, E., Ramnarayan, P., Ramanan, A., Kaleem, M., Tulloh, R., Peters, M. J., Almond, S., Davis, P. J., Levin, M., Faust, S. N., Knight, M., Kenny, S., PIMS-TS National Consensus Management Study Group
10.1101/2020.07.17.20156075 — Posted: 2020-07-23
Surges in COVID-19 are led by lax government interventions in initial outbreaks
Yuan, H.-Y., Wu, L., Wang, D.-P.
10.1101/2020.07.17.20156604 — Posted: 2020-07-23 Discussion: Onsite
Inadequate level of knowledge, mixed outlook and poor adherence to COVID-19 prevention guideline among Ethiopians
Negera, E., Demissie, T. M., Tafess, K.
10.1101/2020.07.22.215590 — Posted: 2020-07-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).